Whalerock Point Partners’s Pfizer PFE Stock Holding History

Whalerock Point Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$876K	Hold	31,206	–	–	0.17%	80
2025 Q4	$777K	Sell	31,206 -5,820	-16%	-$147K	0.15%	84
2025 Q3	$943K	Hold	37,026	–	–	0.19%	72
2025 Q2	$898K	Sell	37,026 -150	-0.4%	-$3.5K	0.19%	76
2025 Q1	$942K	Sell	37,176 -500	-1%	-$13.1K	0.22%	68
2024 Q4	$1,000K	Sell	37,676 -4,000	-10%	-$108K	0.23%	63
2024 Q3	$1.21M	Sell	41,676 -39	-0.1%	-$1.14K	0.29%	59
2024 Q2	$1.17M	Buy	41,715 +39	+0.1%	+$1.07K	0.31%	55
2024 Q1	$1.16M	Sell	41,676 -5,575	-12%	-$155K	0.32%	60
2023 Q4	$1.36M	Sell	47,251 -908	-2%	-$27.4K	0.42%	53
2023 Q3	$1.6M	Sell	48,159 -2,600	-5%	-$91.9K	0.55%	45
2023 Q2	$1.86M	Buy	50,759 +276	+0.5%	+$10.7K	0.63%	42
2023 Q1	$2.06M	Buy	50,483 +2,690	+6%	+$116K	0.77%	38
2022 Q4	$2.45M	Buy	47,793 +483	+1%	+$23.2K	1%	35
2022 Q3	$2.07M	Buy	47,310 +1,645	+4%	+$79.9K	0.91%	36
2022 Q2	$2.39M	Buy	45,665 +50	+0.1%	+$2.55K	1.01%	34
2022 Q1	$2.36M	Buy	45,615 +300	+0.7%	+$15.6K	0.84%	37
2021 Q4	$2.68M	Buy	45,315 +825	+2%	+$40.9K	0.92%	31
2021 Q3	$1.91M	Buy	44,490 +1,300	+3%	+$57.6K	0.74%	39
2021 Q2	$1.69M	Sell	43,190 -100	-0.2%	-$3.89K	0.65%	44
2021 Q1	$1.57M	Sell	43,290 -9,150	-17%	-$325K	0.69%	39
2020 Q4	$1.93M	Buy	52,440 +50,564	+2,695%	+$1.85M	0.92%	37
2020 Q3	$1.78M	Sell	1,876 -47,757	-96%	-$1.67M	0.98%	34
2020 Q2	$1.54M	Sell	49,633 -33,336	-40%	-$1.13M	0.91%	35
2020 Q1	$2.57M	Sell	82,969 -207	-0.2%	-$7.05K	1.84%	15
2019 Q4	$3.09M	Sell	83,176 -22,038	-21%	-$785K	1.64%	14
2019 Q3	$3.59M	Sell	105,214 -225	-0.2%	-$8.18K	1.93%	13
2019 Q2	$4.33M	Hold	105,439	–	–	2.48%	9
2019 Q1	$4.25M	Buy	105,439 +8,010	+8%	+$321K	2.78%	7
2018 Q4	$4.04M	Hold	97,429	–	–	3.75%	6
2018 Q3	$4.07M	Hold	97,429	–	–	2.96%	8
2018 Q2	$3.35M	Sell	97,429 -9,749	-9%	-$333K	2.68%	8
2018 Q1	$3.61M	Sell	107,178 -105	-0.1%	-$3.61K	1.16%	14
2017 Q4	$3.69M	Sell	107,283 -791	-0.7%	-$27K	1.17%	14
2017 Q3	$3.66M	Sell	108,074 -5,897	-5%	-$190K	1.29%	12
2017 Q2	$3.63M	Hold	113,971	–	–	1.33%	12
2017 Q1	$3.7M	Sell	113,971 -1,212	-1%	-$38.2K	1.38%	12
2016 Q4	$3.55M	Sell	115,183 -4,532	-4%	-$138K	1.4%	12
2016 Q3	$3.85M	Buy	+119,715	New	+$4M	1.59%	13
2016 Q1	$3.37M	Sell	119,715 -2,202	-2%	-$62.9K	1.45%	16
2015 Q4	$3.73M	Sell	121,917 -1,181	-1%	-$37.2K	1.62%	13
2015 Q3	$3.67M	Buy	123,098 +3,975	+3%	+$127K	1.58%	11
2015 Q2	$3.79M	Buy	119,123 +712	+0.6%	+$23.2K	1.57%	11
2015 Q1	$3.91M	Sell	118,411 -5,270	-4%	-$168K	1.59%	11
2014 Q4	$3.65M	Sell	123,681 -1,054	-0.8%	-$30.2K	1.54%	12
2014 Q3	$3.5M	Sell	124,735 -579	-0.5%	-$16.3K	1.58%	11
2014 Q2	$3.53M	Buy	125,314 +628	+0.5%	+$17.9K	1.68%	9
2014 Q1	$3.8M	Buy	124,686 +1,054	+0.9%	+$31.4K	1.94%	8
2013 Q4	$3.59M	Buy	+123,632	New	+$3.6M	1.88%	10

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Whalerock Point Partners's PFE Position: Q1 2026 in Review

Whalerock Point Partners held its Pfizer (PFE) position steady in Q1 2026 at 31,206 shares worth $876K. The position accounts for 0.17% of the portfolio, ranked #80.

Whalerock Point Partners first reported a position in PFE in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.33M in Q2 2019. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Whalerock Point Partners held 31,206 shares of Pfizer worth $876K as of Q1 2026.
Whalerock Point Partners left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.17% of Whalerock Point Partners's portfolio in Q1 2026, its #80 holding.
Whalerock Point Partners first reported a position in Pfizer in Q4 2013 and has held it in 49 quarters since.
Whalerock Point Partners's Pfizer position peaked at $4.33M in Q2 2019.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.